CAPD patient inclusion criteria were CAPD patient with dialysis before enrolled for at least three months,
Conditions
Interventions
split dose group was given ergocalciferol 20,
000 IU on thrice a week ,ergocalciferol 60,
000 IU once weekly for 8 weeks
Active Comparator Drug,Active Comparator Drug
ergocalciferol 20,
000 IU on once a week
Sponsors
None
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: inclusion criteria were CAPD patient with dialysis before enrolled for at least three months, aged > 18 years, who were diagnosed vitamin D deficiency and insufficiency, defined by vitamin D insufficiency was of 20–29 ng/mL and deficiency was less than 20 ng/mL.
Exclusion criteria
Exclusion criteria: Subjects with history of liver diseases, patients known to have hypocalcaemia, hypercalcaemia or hyperparathyroidism, pregnant and lactating women, and history of urinary tract stone were excluded from the study. Discontinuation criteria included unwillingness to continue study, intolerable side-effects or allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum 25(OH)D concentrations 8 weeks Level of serum 25(OH)D concentrations | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety profile 4 and 8 weeks Level of calcium and phosphate concentrations | — |
Countries
Thailand
Contacts
Public ContactNaowanit Nata
Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine
Outcome results
None listed